Back to Stakeholders

Thailand’s highest-ranked research university, comprising 17 faculties including the Faculty of Medicine Siriraj Hospital and Ramathibodi Hospital in Bangkok; Mahidol University researchers have conducted a randomized controlled pilot trial of three consecutive daily IV ketamine infusions for treatment-resistant depression and published multiple studies and reviews on ketamine and esketamine efficacy and safety in major depressive disorder.

Quick Facts

Type
Other
HQ
Thailand
Website
Visit

Sponsored Trials

1